These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 20519716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Peptides for cell-selective drug delivery.
    Svensen N, Walton JG, Bradley M.
    Trends Pharmacol Sci; 2012 Apr; 33(4):186-92. PubMed ID: 22424670
    [Abstract] [Full Text] [Related]

  • 3. De novo design of a tumor-penetrating peptide.
    Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi GP, Ruoslahti E.
    Cancer Res; 2013 Jan 15; 73(2):804-12. PubMed ID: 23151901
    [Abstract] [Full Text] [Related]

  • 4. Tissue-penetrating delivery of compounds and nanoparticles into tumors.
    Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E.
    Cancer Cell; 2009 Dec 08; 16(6):510-20. PubMed ID: 19962669
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cell-penetrating peptides: strategies for anticancer treatment.
    Raucher D, Ryu JS.
    Trends Mol Med; 2015 Sep 08; 21(9):560-70. PubMed ID: 26186888
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.
    Xia H, Gu G, Hu Q, Liu Z, Jiang M, Kang T, Miao D, Song Q, Yao L, Tu Y, Chen H, Gao X, Chen J.
    Bioconjug Chem; 2013 Mar 20; 24(3):419-30. PubMed ID: 23350619
    [Abstract] [Full Text] [Related]

  • 12. Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.
    Kadonosono T, Yamano A, Goto T, Tsubaki T, Niibori M, Kuchimaru T, Kizaka-Kondoh S.
    J Control Release; 2015 Mar 10; 201():14-21. PubMed ID: 25592386
    [Abstract] [Full Text] [Related]

  • 13. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
    Kouchakzadeh H, Safavi MS, Shojaosadati SA.
    Adv Protein Chem Struct Biol; 2015 Mar 10; 98():121-43. PubMed ID: 25819278
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. iRGD as a tumor‑penetrating peptide for cancer therapy (Review).
    Yin H, Yang J, Zhang Q, Yang J, Wang H, Xu J, Zheng J.
    Mol Med Rep; 2017 May 10; 15(5):2925-2930. PubMed ID: 28358432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Poly(ornithine-co-arginine-co-glycine-co-aspartic Acid): Preparation via NCA Polymerization and its Potential as a Polymeric Tumor-Penetrating Agent.
    Yu H, Tang Z, Zhang D, Song W, Duan T, Gu J, Chen X.
    Macromol Biosci; 2015 Jun 10; 15(6):829-38. PubMed ID: 25740002
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.